Literature DB >> 28715843

The Pharmaceuticalization of the Tobacco Industry.

Yogi Hale Hendlin1, Jesse Elias1, Pamela M Ling1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28715843      PMCID： PMC5568794          DOI： 10.7326/M17-0759

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  3 in total

1.  The pharmaceuticalisation of society? A framework for analysis.

Authors:  Simon J Williams; Paul Martin; Jonathan Gabe
Journal:  Sociol Health Illn       Date:  2011-03-04

2.  Clarification of When Products Made or Derived From Tobacco Are Regulated as Drugs, Devices, or Combination Products; Amendments to zzm321990Regulations Regarding "Intended Uses." Final rule.

Authors: 
Journal:  Fed Regist       Date:  2017-01-09

3.  Electronic nicotine delivery systems: executive summary of a policy position paper from the American College of Physicians.

Authors:  Ryan A Crowley
Journal:  Ann Intern Med       Date:  2015-04-21       Impact factor: 25.391
  3 in total
  11 in total

1.  Philip Morris International introduces new heat-not-burn product, IQOS, in South Korea.

Authors:  Minji Kim
Journal:  Tob Control       Date:  2017-11-23       Impact factor: 7.552

2.  Regulating Cannabis Manufacturing: Applying Public Health Best Practices from Tobacco Control.

Authors:  Daniel G Orenstein; Stanton A Glantz
Journal:  J Psychoactive Drugs       Date:  2018-02-13

Review 3.  Moving targets: how the rapidly changing tobacco and nicotine landscape creates advertising and promotion policy challenges.

Authors:  Pamela M Ling; Minji Kim; Catherine O Egbe; Roengrudee Patanavanich; Mariana Pinho; Yogi Hendlin
Journal:  Tob Control       Date:  2022-03       Impact factor: 6.953

4.  Origins of tobacco harm reduction in the UK: the 'Product Modification Programme' (1972-1991).

Authors:  Jesse Elias; Pamela M Ling
Journal:  Tob Control       Date:  2018-01-12       Impact factor: 7.552

5.  Heated tobacco product use among Korean adolescents.

Authors:  Heewon Kang; Sung-Il Cho
Journal:  Tob Control       Date:  2019-06-04       Impact factor: 7.552

6.  Invisible smoke: third-party endorsement and the resurrection of heat-not-burn tobacco products.

Authors:  Jesse Elias; Pamela M Ling
Journal:  Tob Control       Date:  2018-06-06       Impact factor: 7.552

7.  IQOS labelling will mislead consumers.

Authors:  Karma McKelvey; Lucy Popova; Minji Kim; Lauren Kass Lempert; Benjamin W Chaffee; Maya Vijayaraghavan; Pamela Ling; Bonnie Halpern-Felsher
Journal:  Tob Control       Date:  2018-08-29       Impact factor: 7.552

8.  Cigarette smokers' concurrent use of smokeless tobacco: dual use patterns and nicotine exposure.

Authors:  Nicholas J Felicione; Jenny E Ozga-Hess; Stuart G Ferguson; Geri Dino; Summer Kuhn; Ilana Haliwa; Melissa D Blank
Journal:  Tob Control       Date:  2020-02-12       Impact factor: 7.552

9.  Public versus internal conceptions of addiction: An analysis of internal Philip Morris documents.

Authors:  Jesse Elias; Yogi Hale Hendlin; Pamela M Ling
Journal:  PLoS Med       Date:  2018-05-01       Impact factor: 11.069

10.  Longitudinal transitions of cigarettes and electronic nicotine delivery systems among adolescents: Construction of a retrospective cohort using recall data from a cross-sectional sample.

Authors:  Heewon Kang; Sung-Il Cho
Journal:  Tob Induc Dis       Date:  2020-11-05       Impact factor: 2.600
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.